DEBA PHARMA

DEBA PHARMA has been active since 1988 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €6.2m and a net result of €2.1m. Equity is growing by ~11.8% per year across the filed fiscal years. Its solvency ranks better than 94% of 88 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).